A group of patients have launched a charter challenge to help them get access to what they say is life-saving treatment of psilocybin mushrooms.
Psilocybin, more commonly referred to as magic mushrooms, is seen as a way to treat extreme cases of anxiety and depression.
Sam Riches, who writes for the National Post and the GrowthOp, joins Dave Breakenridge to discuss why psilocybin is seen as a viable treatment in these cases, how hard it is to access, and why these patients are suing the government.
Background reading: Canadian patients fighting for psilocybin access sue federal government
Learn more about your ad choices. Visit megaphone.fm/adchoices
